RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

“There’s no centralised national screening programme and things need to change to provide better healthcare for New Zealand men,” he said. The Prostate Cancer Foundation is asking the ...

A study of men with a family history of prostate cancer has discovered ... from the Veterans Health Administration, the V Foundation for Cancer Research, and National Institutes of Health grant ...

Howard R. Soule, Ph.D., executive vice president and chief science officer of the Prostate Cancer Foundation, said, "These findings fill a therapeutic gap for patients with advanced prostate cancer.

In research funded largely by Prostate Cancer UK, Movember, and the Prostate Cancer Foundation, they found an association between higher levels of heat shock proteins and more androgen receptor ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...

The waters of Niagara Falls were illuminated blue on Sunday night to raise awareness for prostate cancer and honor a Utica ...

Howard R. Soule, PhD, Executive Vice President and Chief Science Officer of the Prostate Cancer Foundation, said: “These findings fill a therapeutic gap for patients with advanced prostate cancer. We ...